SlimCrystal

Report from the 2024 ACI-CRN Legal, Regulatory and Compliance Forum

Operating in an environment where so many triggers lie beyond business-as-usual and immediate grasp, industry lawyers at last week’s ACI-CRN Legal, Regulatory & Compliance Forum on Dietary Supplements addressed some of the myriad issues now front of mind.

If last year’s forum featured a whiplashed industry​ impacted by unprecedented regulatory activity and open-ended questions, this year there was a sense that stakeholders need clarity, process and enforcement to avoid any further disorientation, particularly in the face of increasing existential threats.

sumatra ad banner

Considering legislative updates and the tools in the toolbox​

On the eve of the 30th anniversary of the passing of the Dietary Supplement Health and Education Act (DSHEA), the statute that created the modern dietary supplement industry, speakers at the forum echoed discussions taking place across other industry events. 

The general premise is that while DSHEA protected the industry and allowed it to thrive, there are also elements of the law that may be stifling, unenforced and/or misconstrued. 

“The pivotal piece of legislation enacted in 1994 has been the cornerstone of our regulatory framework for dietary supplements for nearly three decades,” said Megan Olson, forum co-chair and senior vice president and general counsel at the Council for Responsible Nutrition (CRN). “However, as our industry grows and evolves, so too should the regulations that govern it.”

One hot topic that arose was FDA’s current interpretation of the drug preclusion provision, which was added to DSHEA last minute but intended to balance and protect the interests of the drug industry by ensuring that articles first approved as drugs could not be marketed as dietary supplements. What has evolved, however, is a bit less clear cut, with the dietary supplement side arguing disadvantage due to surprise and/or questionable preclusion. 


Source link

sumatra ad banner

Written by : Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.

Share this article:

Leave A Comment